| |
|
|
|
Immucell Cp  
|
|
7.1 0.45 (0.07%) |
01-20 10:45 |
|
Open: |
6.79 |
Pre close: |
6.65 |
Target:
|
8.63 
|
|
High: |
7.39 |
Low: |
6.79 |
Resistance:
|
7.39
8.63
|
|
Volume: |
84,940 |
Market Cap: |
51M |
Support:
|
6.33
5.67
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.48
|
MACD |
MACD(12,26):
|
0.14 |
|
MA(20): |
6.26 |
Signal(12,26,9): |
0.08 |
|
MA(100): |
5.76 |
Stochastic Oscillator |
%K(14,3):
|
65.26 |
|
MA(250): |
5.22 |
%D(3): |
63.55 |
|
Average Volume(K) |
3-Month: |
1044
|
52-Week |
High:
|
7.39 |
|
10-Days: |
2505 |
Low: |
3.70 |
|
RSI |
RSI(14):
|
69.29 |
Change(%): |
33.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.210 |
Return on Equity (ttm) |
-5.3 |
Shares Out. (M) |
7.21 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-1.6 |
Shares Float (M) |
5.16 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.86 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
25.3 |
% Held by Institutions |
10.03 |
|
Forward EPS |
-0.030 |
Gross Profit (p.s.) |
0.935 |
Shares Short (K) |
6 |
|
Book Value (p.s.) |
3.880 |
EBITDA (p.s.) |
0.182 |
P/E |
-33.05 |
|
Sales Per Share |
2.112 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.79 |
|
Profit Margin |
-9.99 |
Operating Cash Flow
(M) |
1.11 |
P/S |
3.29 |
|
Operating Margin |
-6.49 |
Levered Free Cash Flow
(M) |
-2.68 |
P/CF |
45.08 |
|
|
|
|
|
|
